Drawing for LUNAPHORE

USPTO serial 79179383

LUNAPHORE

Reviewed by CopyMark Law Group

Reg. 5361858Status 706Renewal
Filing date
Status date
Registration date
Dec 26, 2017
Examiner
HENRY, NAKIA D
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with LUNAPHORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Courtney Thompson

Courtney Thompson Fredrikson & Byron, P.A.60 South Sixth Street, Suite 1500Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic substances, preparations and agents for medical purposes; diagnostic reagents [ and contrast media ] for medical purposes; [ contrast media for use with medical equipment; ] diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical purposes; diagnostic test reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids [; biotechnological preparations for medical purposes for the treatment of cancer and metabolic diseases ]ACTIVE—
009Scientific apparatus and instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms; optical apparatus and instruments, namely, microscopes, optical profilers, optical filters, optical glasses, optical lens sights, optical scanners, optical readers, optical reflectors; [ weighing apparatus and instruments, namely, scales and balances; ] measuring apparatus and instruments, namely, instruments for measuring the quantity of contaminants, pollutants, or malignant cells in human, animal, plant, or microorganism cells and tissues; signaling apparatus and instruments, namely, signal processors, and signal splitters for electronic apparatus; measuring and testing machines and instruments, namely, digitizers; laboratory apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; microfluidic testing apparatus not for medical purposes in the form of assay chips, biological assay chips, and sample processing chips; microfluidic systems, namely, sample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubes, reservoirs, pumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidics, not for medical purposes used to diagnose cancer; chips, namely, integrated circuits; microfluidic chips in the nature of integrated circuits; [ DNA chips; ] biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chips, namely, microchips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatus, instruments and devices, namely, calculating machines, central processing units and computers for the input, output, transmission, storage, and processing of data, in particular scientific and medical data; Software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms collected via immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencingACTIVE—
010Medical apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing using fluid technology; diagnostic apparatus for medical purpose; microfluidic testing apparatus for medical purposes for testing biomarker expression levels in cell and tissue samplesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 7, 2025INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 21, 2025INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 20, 2025INPCINVALIDATION PROCESSED—
Jun 5, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
May 18, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 18, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 18, 202471AGREGISTERED-SEC.71 ACCEPTED—
Sep 16, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 22, 2023ES71TEAS SECTION 71 RECEIVED—
Nov 10, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 6, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 6, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 6, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 6, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 6, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 26, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 5, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 5, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 5, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 5, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 5, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 5, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 27, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 19, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 2, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 2, 2018FIMPFINAL DISPOSITION PROCESSED—
Mar 26, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 26, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 17, 2017GPNXNOTIFICATION PROCESSED BY IB—
Oct 10, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 10, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 20, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 20, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 20, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 5, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 16, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 15, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Aug 15, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 15, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 15, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 8, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 21, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 21, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 14, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 14, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 14, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 24, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2016ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 26, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 2, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 2, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2016ALIEASSIGNED TO LIE—
Aug 29, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2016CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Mar 26, 2016RFNTREFUSAL PROCESSED BY IB—
Mar 8, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 8, 2016RFRRREFUSAL PROCESSED BY MPU—
Mar 5, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2016DOCKASSIGNED TO EXAMINER—
Jan 22, 2016CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jan 5, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 31, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 30, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance